AmgenvsBrightSpring Health Services

AMGN and BTSG stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$445.87

Value $240B

-2.63%
AMGN's page

BTSG

BrightSpring Health Services, Inc.

$69.42

Value $13.4B

-0.58%
BTSG's page

Amgen (AMGN) has a market value of $240B and BrightSpring Health Services (BTSG) $13.4B. Over the last year, with dividends, AMGN moved +34.1% and BTSG +121.4%. The P/E is 25.6 for AMGN and 32.8 for BTSG. Dividend yield: AMGN 2.23%, BTSG none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$240B

    BTSG$13.4B

    AMGN is 18 times BTSG

  • Revenue, 12 months

    AMGN$38.9B

    BTSG$15.3B

    AMGN is 2.6 times BTSG

  • Net income, 12 months

    AMGN$9.4B

    BTSG$410M

    AMGN is 23 times BTSG

  • Operating margin

    AMGN32.4%

    BTSG3.4%

    29.0 points apart

  • ROIC

    AMGN16.2%

    BTSG9.9%

    6.3 points apart

  • P/E

    AMGN25.6

    BTSG32.8

    BTSG is 1.3 times AMGN

  • Dividend yield

    AMGN2.2%

    BTSG0.0%

    2.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+34.1%

BTSG+121.4%

100150200DecFebAprJunAugOct
Returns by period
PeriodAMGNWith dividendsBTSGWith dividends
1 year since November 17, 2025+34.1%Price +30.5%+121.4%Price +121.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenBTSGBrightSpring Health Services

Valuation

AMGNBTSG
Valuation
Price$445.87$69.42
Market value$240B$13.4B
Enterprise value (EV)$281B$14.9B
P/E25.632.8
P/E, 5-year median23.0–
P/B16.86.2
EV/EBIT22.328.7
Free cash flow yield4.0%3.7%

Results and growth

AMGNBTSG
Results and growth
Revenue, 12 months$38.9B$15.3B
Net income, 12 months$9.4B$410M
Free cash flow, 12 months$9.6B$492M
Earnings per share, 12 months$17.25$2.12
Revenue growth, year on year10.0%28.2%
Revenue growth a year, past+7.6%over 5 years+18.7%over 3 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNBTSG
Margins and returns on capital
Gross margin70.9%12.5%
Operating margin32.4%3.4%
Net margin24.1%2.7%
ROIC16.2%9.9%
ROE87.8%20.7%

Balance sheet

AMGNBTSG
Balance sheet
Cash$13.2B$718M
Total debt$54.0B$2.4B
Net debt / EBITDA2.32.2
Interest cover4.8×3.6×

Dividends and buybacks

AMGNBTSG
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield–0.3%
Shareholder yield2.2%0.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or BTSG

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or BrightSpring Health Services?

By market value, Amgen ($240B) is about 17.9 times BrightSpring Health Services ($13.4B), at today's prices.

How did AMGN and BTSG stock do over the last 1 years?

Since November 17, 2025, AMGN's price moved +30.5% and BTSG's +121.4%. With dividends: AMGN +34.1% (+34.1% a year), BTSG +121.4% (+121.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or BTSG?

The dividend yield at today's price is 2.23% for Amgen and none for BrightSpring Health Services. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and BTSG?

At today's price, the P/E is 25.6 for AMGN and 32.8 for BTSG. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Amgen or BrightSpring Health Services?

Over the last twelve months, the net margin was 24.1% for Amgen and 2.7% for BrightSpring Health Services, and the operating margin 32.4% and 3.4%. Revenue was $38.9B and $15.3B.

Which is the better investment, Amgen or BrightSpring Health Services?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.